| pubmed-article:19706846 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C0079184 | lld:lifeskim |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C0279781 | lld:lifeskim |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C0334094 | lld:lifeskim |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:19706846 | lifeskim:mentions | umls-concept:C0205170 | lld:lifeskim |
| pubmed-article:19706846 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:19706846 | pubmed:dateCreated | 2009-9-11 | lld:pubmed |
| pubmed-article:19706846 | pubmed:abstractText | Proliferative markers are not recommended as prognostic factors for clinical use in breast cancer due to lack of standardization in methodology. However, proliferation is driving several gene expression signatures emphasizing the need for a reliable proliferative marker for clinical use. Studies suggest that cyclin A is a prognostic marker with satisfying reproducibility. We investigated cyclin A as a prognostic marker in node-negative breast cancer using previously defined cutoff values. Patients and | lld:pubmed |
| pubmed-article:19706846 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19706846 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19706846 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19706846 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19706846 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19706846 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19706846 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19706846 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19706846 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19706846 | pubmed:issn | 1538-7755 | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:HolmbergLarsL | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:BlomqvistCarl... | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:NilssonCecili... | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:AminiRose-Mar... | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:HolmqvistMari... | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:FjällskogMari... | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:ZhouWenjingW | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:JirströmKarin... | lld:pubmed |
| pubmed-article:19706846 | pubmed:author | pubmed-author:AhlinCeciliaC | lld:pubmed |
| pubmed-article:19706846 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19706846 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:19706846 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19706846 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19706846 | pubmed:pagination | 2501-6 | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:meshHeading | pubmed-meshheading:19706846... | lld:pubmed |
| pubmed-article:19706846 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19706846 | pubmed:articleTitle | Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer. | lld:pubmed |
| pubmed-article:19706846 | pubmed:affiliation | Department of Oncology, Uppsala University Hospital, SE-751 85 Uppsala, Sweden. | lld:pubmed |
| pubmed-article:19706846 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19706846 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
